Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 209

1.

Paroxetine in the treatment of depression: a comparison with imipramine and placebo.

Feighner JP, Boyer WF.

J Clin Psychiatry. 1992 Feb;53 Suppl:44-7.

PMID:
1531824
2.

Paroxetine in the treatment of depression: a comparison with imipramine and placebo.

Feighner JP, Boyer WF.

Acta Psychiatr Scand Suppl. 1989;350:125-9.

PMID:
2530763
3.
4.

A double-blind comparison of paroxetine, imipramine, and placebo in major depression.

Shrivastava RK, Shrivastava SH, Overweg N, Blumhardt CL.

J Clin Psychiatry. 1992 Feb;53 Suppl:48-51.

PMID:
1531825
5.

Paroxetine in major depression: a double-blind trial with imipramine and placebo.

Cohn JB, Wilcox CS.

J Clin Psychiatry. 1992 Feb;53 Suppl:52-6.

PMID:
1531826
6.

A double-blind, placebo-controlled study of paroxetine in depressed outpatients.

Kiev A.

J Clin Psychiatry. 1992 Feb;53 Suppl:27-9.

PMID:
1531818
7.

The efficacy and safety of paroxetine compared with placebo in outpatients with major depression.

Rickels K, Amsterdam J, Clary C, Fox I, Schweizer E, Weise C.

J Clin Psychiatry. 1992 Feb;53 Suppl:30-2.

PMID:
1531820
8.
9.

A placebo-controlled trial of paroxetine in the treatment of major depression.

Smith WT, Glaudin V.

J Clin Psychiatry. 1992 Feb;53 Suppl:36-9.

PMID:
1531822
10.

Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression.

Dunner DL, Cohn JB, Walshe T 3rd, Cohn CK, Feighner JP, Fieve RR, Halikas JP, Hartford JT, Hearst ED, Settle EC Jr, et al.

J Clin Psychiatry. 1992 Feb;53 Suppl:57-60.

PMID:
1531827
11.

A placebo- and imipramine-controlled study of paroxetine.

Cohn JB, Crowder JE, Wilcox CS, Ryan PJ.

Psychopharmacol Bull. 1990;26(2):185-9.

PMID:
2146697
12.

Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.

Schweizer E, Feighner J, Mandos LA, Rickels K.

J Clin Psychiatry. 1994 Mar;55(3):104-8.

PMID:
8071246
13.

The predictive value of the dexamethasone suppression test. A placebo-controlled study.

Peselow ED, Stanley M, Filippi AM, Barouche F, Goodnick P, Fieve RR.

Br J Psychiatry. 1989 Nov;155:667-72.

PMID:
2532946
14.

A double-blind comparison of nefazodone, imipramine, and placebo in major depression.

Fontaine R, Ontiveros A, Elie R, Kensler TT, Roberts DL, Kaplita S, Ecker JA, Faludi G.

J Clin Psychiatry. 1994 Jun;55(6):234-41.

PMID:
8071277
15.

A double-blind comparison of paroxetine, imipramine and placebo in depressed outpatients.

Feighner JP.

Int Clin Psychopharmacol. 1992 Jun;6 Suppl 4:31-5.

PMID:
1431008
16.

A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.

Dominguez RA, Goldstein BJ, Jacobson AF, Steinbook RM.

J Clin Psychiatry. 1985 Mar;46(3):84-7.

PMID:
3918993
17.

A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression.

Lydiard RB, Stahl SM, Hertzman M, Harrison WM.

J Clin Psychiatry. 1997 Nov;58(11):484-91.

PMID:
9413414
18.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
19.

An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder.

Preskorn SH, Baker B, Kolluri S, Menniti FS, Krams M, Landen JW.

J Clin Psychopharmacol. 2008 Dec;28(6):631-7. doi: 10.1097/JCP.0b013e31818a6cea.

PMID:
19011431
20.

The short- and long-term efficacy of paroxetine HCl: A. Data from a 6-week double-blind parallel design trial vs. imipramine and placebo.

Peselow ED, Filippi AM, Goodnick P, Barouche F, Fieve RR.

Psychopharmacol Bull. 1989;25(2):267-71. No abstract available.

PMID:
2532373

Supplemental Content

Support Center